Revised: 7 November 2019

Information for Healthcare Professionals

This section provides information useful to healthcare professionals.

Medsafe Advice

Date Type Title
3/12/2020PublicationsPrescriber Update - Vol. 41 No. 4 December 2020
19/11/2020CommitteesAgenda for the 184th Medicines Adverse Reactions Committee meeting - 3 December 2020
18/11/2020CommitteesMedicines Classification Committee - Dates and Deadlines
17/11/2020Dear Healthcare Professional LetterMinirin Letter to Pharmacist and Letter to Prescriber - Notification of shortage of Minirin (desmopressin acetate) nasal drops
6/11/2020Alert CommunicationUpdate to Original Communication - Important updates to clozapine data sheets and monitoring during covid-19 pandemic
5/11/2020NoticesCodeine-containing medicines have now been reclassified
The recommendations from the 59th MCC meeting has been gazetted today
3/11/2020NoticesNotice of Medsafe Office Closure Christmas/New Year 2020/2021
30/10/2020Monitoring CommunicationUPDATE: Concern reported with the use of NovoRapid® Penfill® (insulin aspart; 3 mL cartridge) by type 1 diabetes patients
23/10/2020CommitteesComments on agenda for 65th Medicines Classificaton Committee meeting
23/10/2020Monitoring CommunicationConcern reported with the use of NovoRapid® Penfill® (insulin aspart; 3 mL cartridge) by type 1 diabetes patients
22/10/2020Media ReleaseCodeine-containing medicines to be reclassified
19/10/2020NoticesInfluenza Vaccine Composition - 2021
14/10/2020CommitteesAgenda for the 65th Medicines Classification Committee meeting Please note there have been some changes to the agenda relating to removing New Chemical Entities that were classified at the 64th meeting of the MCC and clarification of the agenda item Harmonisation of the NZ and Australian schedules for noting

If you have an enquiry that is not answered by the information on the web site please contact us at askmedsafe@health.govt.nz.

Show menus
0 1 2 4 5 6 7 9 [ /